News and Lectures

Triple-negative breast cancer has been among the most difficult to treat, but the increased understanding of the molecular nature of Triple-negative breast cancer expand treatment options in this breast cancer subset. https://www.youtube.com/watch?app=desktop&v=6kNKU8PgCAA

data indicate that a substantial knowledge gap exists regarding the latest developments in the treatment of metastatic TNBC. Continue

Researchers identified a causative signaling pathway in breast cancer, providing potential new targets for treatment of the most common type of cancer in women.  Continue

Crucial Skills for ScientistsWe are happy to announce a new IVS webinar series, “Crucial Skills for Scientists,”parallel to our ongoing webinar series, “Big Topics from Top Scientists.” In this uniquewebinar series, lectures on a broad range of topics related to… Continue Reading →

Single-cell approaches for studying spatial heterogeneity in the healthy and malignant liverProf. Shalev ItzkovitzDepartment of Molecular Cell BiologyFaculty of Biology 11 November 2021. The liver is a major site of primary tumors and metastases. It is a highlyheterogeneous organ that… Continue Reading →

Melanoma addiction to GCDH defines NRF2 tumor suppressor functionProf. Ze’ev Ronai Director, NCI designated Cancer CenterSanford-Burnham-PrebysMedical Discovery Institute18 November 2021 Tumor dependency on specific metabolic signals has guided numerous therapeuticapproaches. Here we identify melanoma addiction to the lysine metabolism pathway,which… Continue Reading →

mRNA based vaccines prevent COVID-19 infections, putting them at the forefront of the current global fight against the COVID-19 pandemic. The scientific and clinical development of mRNA medicines, which began in ernest only ~10 years ago, has the potential to… Continue Reading →

The annual clinical research conference in Israel will be held on February 3 at the David Intercontinental Hotel in Tel Aviv. Attached are the lecture topics at the conference: